Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Vinod Pant Image

      Vinod Pant, Ph.D.

      Department of Genetics, Division of Discovery Science

      About Dr. Vinod Pant

      Dr. Pant is a cancer geneticist who is interested in understanding the regulation and function of the p53 tumor suppressor pathway. Originally from India, Dr. Pant finished his graduate studies in Developmental Biology and Genetics from Uppsala University, Sweden. He later joined the Department of Genetics, MD Anderson Cancer Center for his post-doctoral training and was promoted to Instructor and Assistant Professor positions. Dr. Pant is an expert in genetic models and has generated multiple mouse models that have provided key insights into the role of negative regulators of the p53 tumor suppressor pathway. Dr. Pant’s research is focused on understanding the regulation of p53 during development, DNA damage and disease conditions. The p53 tumor suppressor protein is highly regulated in vivo by Mdm2 and Mdm4. To characterize the role of these regulators, Dr. Pant generated mouse models and showed that heterodimerization between Mdm2 and Mdm4 through their respective RING domains is critical for regulating p53 activity during early embryogenesis but is not important for the stability of p53 and Mdm2. In another project, Dr. Pant showed that in contrast to the prevailing dogma, the p53-Mdm2 feedback loop is dispensable for normal development, and longevity. However, it is critically required for regulating p53 activity after genotoxic damage. He has used these mice to further show that p53 plays a paradoxical role in hematopoietic and gastrointestinal compartments. Feedback deficient mice undergo p53-dependent bone marrow failure after sub-lethal IR, but are resistant to gastrointestinal toxicity following high dose shielded body radiation. These studies have implications towards designing of future approaches to regulate p53 in clinical settings. Additionally, Dr. Pant has actively collaborated with other researchers and has been supported by NIH training grant and fellowships from various foundations

      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Dept. of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Associate Professor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests

      Dr. Pant’s research is focused on understanding the regulation of p53 during development, DNA damage and disease conditions. The p53 tumor suppressor protein is highly regulated in vivo by Mdm2 and Mdm4. To characterize the role of these regulators, Dr. Pant generated mouse models and showed that heterodimerization between Mdm2 and Mdm4 through their respective RING domains is critical for regulating p53 activity during early embryogenesis but is not important for the stability of p53 and Mdm2. In another project, Dr. Pant showed that in contrast to the prevailing dogma, the p53-Mdm2 feedback loop is dispensable for normal development, and longevity. However, it is critically required for regulating p53 activity after genotoxic damage. He has used these mice to further show that p53 plays a paradoxical role in hematopoietic and gastrointestinal compartments. Feedback deficient mice undergo p53-dependent bone marrow failure after sub-lethal IR, but are resistant to gastrointestinal toxicity following high dose shielded body radiation. These studies have implications towards designing of future approaches to regulate p53 in clinical settings. Additionally, Dr. Pant has actively collaborated with other researchers and has been supported by NIH training grant and fellowships from various foundations.

      Education & Training

      Degree-Granting Education

      2003Uppsala University, Uppsala, SE, Developmental Biology & Genetics, Ph.D

      Postgraduate Training

      2005-2011Postdoctoral Fellow, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
      2004-2005Postdoctoral Associate, Baylor College of Medicine, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2023

      Instructor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2014

      Intramural Institutional Committee Activities

      Member, MD Anderson - Institutional Animal Care and Use Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Professional Memberships

      American Association for Cancer Research

      2018 - Present

      Grant & Contract Support

      Date: 2020 - 2025
      Title:Identifying the vulnerabilities in Mdm2 overexpressing cancer cells
      Funding Source:NIH/NCI
      Role:PI
      ID:R50 CA251703-01
      Date: 2004 - 2010
      Title:Molecular Genetics of Cancer Training Grant
      Funding Source:NIH/NCI
      Role:Postdoctoral Fellow
      ID:T32-CA009299
      Date: 1988 - 2027
      Title:A Pathway of Tumor Suppression
      Funding Source:NIH/NCI
      Role:Co-I
      ID:2R01 CA047296

      Selected Publications

      Peer-Reviewed Articles

      1. Xiong S, Zhang Y, Zhou X, Pant V, Mirani A, Gencel-Augusto J, Chau G, You M, Lozano G. Dependence on Mdm2 for Mdm4 inhibition of p53 activity. Cancer Lett, 2025. e-Pub 2025. PMID: 40081463.
      2. Gencel-Augusto, J, Su, X, Qi, Y, Whitley, EM, Pant, V, Xiong, S, Shah, VV, Lin, J, Perez, E, Fiorotto, M, Mahmud, I, Jain, A, Lorenzi, PL, Navin, N, Richie, ER, Lozano, G. Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program. Cancer discovery 13(5):1230-1249, 2023. e-Pub 2023. PMID: 37067911.
      3. Xiong S, Chachad D, Zhang Y, Gencel-Augusto J, Sirito M, Pant V, Yang P, Sun C, Chau G, Qi Y, Su X, Whitley EM, El-Naggar AK, Lozano G. Differential gain-of-function activity of three p53 hotspot mutants in vivo. Cancer Res 82(10):1926-1936, 2022. e-Pub 2022. PMID: 35320355.
      4. Pant V, Aryal NK, Xiong S, Chau GP, Fowlkes NW, Lozano G. Alterations of the MDM2 C-terminus differentially impact its function in vivo. Cancer Res 82(7):1313-1320, 2022. e-Pub 2022. PMID: 35078816.
      5. Pant V, Xiong S, Wasylishen AR, Larsson CA, Aryal NK, Chau G, Tailor RC, Lozano G. Transient enhancement of p53 activity protects from radiation-induced gastrointestinal toxicity. Proc Natl Acad Sci U S A 116(35):17429-17437, 2019. e-Pub 2019. PMID: 31409715.
      6. Aryal NK, Pant V, Wasylishen AR, Rimel BJ, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G. Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination. Cancer Res 79(10):2662-2668, 2019. e-Pub 2019. PMID: 30914430.
      7. Aryal NK, Pant V, Wasylishen AR, Parker-Thornburg J, Baseler L, El-Naggar AK, Liu B, Kalia A, Lozano G, Arur S. Constitutive Dicer1 phosphorylation accelerates metabolism and aging in vivo. Proc Natl Acad Sci U S A 116(3):960-969, 2019. e-Pub 2019. PMID: 30593561.
      8. Wasylishen AR, Estrella JS, Pant V, Chau GP, Lozano G. Daxx Functions are p53-independent In Vivo. Mol Cancer Res 16(10):1523-1529, 2018. e-Pub 2018. PMID: 29903771.
      9. Zhang Y, Xiong S, Liu B, Pant V, Celii F, Chau G, Elizondo-Fraire AC, Yang P, You MJ, El-Naggar AK, Navin NE, Lozano G. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases. Nat Commun 9(1):3953, 2018. e-Pub 2018. PMID: 30262850.
      10. Larsson CA, Moyer SM, Liu B, Michel KA, Pant V, Yang P, Wong J, El-Naggar AK, Krahe R, Lozano G. Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration. Proc Natl Acad Sci U S A 115(9):2198-2203, 2018. e-Pub 2018. PMID: 29440484.
      11. Ortiz GJ, Li Y, Post SM, Pant V, Xiong S, Larsson CA, El-Naggar AK, Johnson DG, Lozano G. Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes. Oncogene 37(3):332-340, 2018. e-Pub 2018. PMID: 28925402.
      12. Aryal NK, Wasylishen AR, Pant V, Riley-Croce M, Lozano G. Loss of digestive organ expansion factor (Diexf) reveals an essential role during murine embryonic development that is independent of p53. Oncotarget 8(61):103996-104006, 2017. e-Pub 2017. PMID: 29262616.
      13. Pant V, Larsson CA, Aryal N, Xiong S, You MJ, Quintas-Cardama A, Lozano G. Tumorigenesis promotes Mdm4-S overexpression. Oncotarget 8(16):25837-25847, 2017. e-Pub 2017. PMID: 28460439.
      14. Xiong S, Pant V, Zhang Y, Aryal NK, You MJ, Kusewitt D, Lozano G. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis. J Pathol 241(4):501-510, 2017. e-Pub 2017. PMID: 27925213.
      15. Pant V, Xiong S, Chau G, Tsai K, Shetty G, Lozano G. Distinct downstream targets manifest p53-dependent pathologies in mice. Oncogene 35(44):5713-5721, 2016. e-Pub 2016. PMID: 27065327.
      16. Jiang S, Minter LC, Stratton SA, Yang P, Abbas HA, Akdemir ZC, Pant V, Post S, Gagea M, Lee RG, Lozano G, Barton MC. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. J Hepatol 62(2):371-9, 2015. e-Pub 2015. PMID: 25281858.
      17. Xiong S, Tu H, Kollareddy M, Pant V, Li Q, Zhang Y, Jackson JG, Suh YA, Elizondo-Fraire AC, Yang P, Chau G, Tashakori M, Wasylishen AR, Ju Z, Solomon H, Rotter V, Liu B, El-Naggar AK, Donehower LA, Martinez LA, Lozano G. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proc Natl Acad Sci U S A 111(30):11145-50, 2014. e-Pub 2014. PMID: 25024203.
      18. Pant V, Xiong S, Jackson JG, Post SM, Abbas HA, Quintás-Cardama A, Hamir AN, Lozano G. The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Genes Dev 27(17):1857-67, 2013. e-Pub 2013. PMID: 23973961.
      19. Jackson JG, Pant V, Li Q, Chang LL, Quintás-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, El-Naggar AK, Lozano G. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 21(6):793-806, 2012. e-Pub 2012. PMID: 22698404.
      20. Guibert S, Zhao Z, Sjölinder M, Göndör A, Fernandez A, Pant V, Ohlsson R. CTCF-binding sites within the H19 ICR differentially regulate local chromatin structures and cis-acting functions. Epigenetics 7(4):361-9, 2012. e-Pub 2012. PMID: 22415163.
      21. Pant V, Xiong S, Iwakuma T, Quintás-Cardama A, Lozano G. Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proc Natl Acad Sci U S A 108(29):11995-2000, 2011. e-Pub 2011. PMID: 21730132.
      22. Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, Post SM, Lozano G. Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4. Cancer Res 70(18):7148-54, 2010. e-Pub 2010. PMID: 20736370.
      23. Post SM, Quintás-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, Lozano G. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell 18(3):220-30, 2010. e-Pub 2010. PMID: 20832750.
      24. Zhao Z, Tavoosidana G, Sjölinder M, Göndör A, Mariano P, Wang S, Kanduri C, Lezcano M, Sandhu KS, Singh U, Pant V, Tiwari V, Kurukuti S, Ohlsson R. Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat Genet 38(11):1341-7, 2006. e-Pub 2006. PMID: 17033624.
      25. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Farrar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, Oshimura M, Feinberg AP, Lobanenkov V, Klenova E, Ohlsson R. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 36(10):1105-10, 2004. e-Pub 2004. PMID: 15361875.
      26. Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R, Klenova E, Lobanenkov V, Ohlsson R. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance. Mol Cell Biol 24(8):3497-504, 2004. e-Pub 2004. PMID: 15060168.
      27. Pant V, Mariano P, Kanduri C, Mattsson A, Lobanenkov V, Heuchel R, Ohlsson R. The nucleotides responsible for the direct physical contact between the chromatin insulator protein CTCF and the H19 imprinting control region manifest parent of origin-specific long-distance insulation and methylation-free domains. Genes Dev 17(5):586-90, 2003. e-Pub 2003. PMID: 12629040.
      28. Ginjala V, Holmgren C, Ullerås E, Kanduri C, Pant V, Lobanenkov V, Franklin G, Ohlsson R. Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer. A cautionary note. J Biol Chem 277(8):5707-10, 2002. e-Pub 2002. PMID: 11777900.
      29. Pant V, Gupta D, Choudhury NR, Malathi VG, Varma A, Mukherjee SK. Molecular characterization of the Rep protein of the blackgram isolate of Indian mungbean yellow mosaic virus. J Gen Virol 82(Pt 10):2559-67, 2001. e-Pub 2001. PMID: 11562548.
      30. Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A, Ohlsson R, Lobanenkov VV. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 10(14):853-6, 2000. e-Pub 2000. PMID: 10899010.
      31. Gaikwad A, Babbarwal V, Pant V, Mukherjee SK. Pea chloroplast FtsZ can form multimers and correct the thermosensitive defect of an Escherichia coli ftsZ mutant. Mol Gen Genet 263(2):213-21, 2000. e-Pub 2000. PMID: 10778739.
      32. Vaishnav YN, Pant V. Differential regulation of E2F transcription factors by p53 tumor suppressor protein. DNA Cell Biol 18(12):911-22, 1999. e-Pub 1999. PMID: 10619603.
      33. Vaishnav YN, Vaishnav MY, Pant V. The molecular and functional characterization of E2F-5 transcription factor. Biochem Biophys Res Commun 242(3):586-92, 1998. e-Pub 1998. PMID: 9464260.

      Invited Articles

      1. Pant V, Sun C, Lozano G. Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program. Cell Death Differ 30(4):897-905, 2023. e-Pub 2023. PMID: 36755072.
      2. Pant V, Lozano G. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev 28(16):1739-51, 2014. e-Pub 2014. PMID: 25128494.
      3. Pant V, Lozano G. Dissecting the p53-Mdm2 feedback loop in vivo: Uncoupling the role in p53 stability and activity. Oncotarget 5(5):1149-56, 2014. e-Pub 2014. PMID: 24658419.
      4. Pant V, Quintás-Cardama A, Lozano G. The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans. Blood 120(26):5118-27, 2012. e-Pub 2012. PMID: 23018641.
      5. Abbas HA, Pant V, Lozano G. The ups and downs of p53 regulation in hematopoietic stem cells. Cell Cycle 10(19):3257-62, 2011. e-Pub 2011. PMID: 21957490.
      6. Post SM, Pant V, Abbas H, Quintás-Cardama A. Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma. Oncotarget 1(3):168-74, 2010. e-Pub 2010. PMID: 21301048.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top